SEARCH

SEARCH BY CITATION

References

  • 1
    Pare P, Ferrazzi S, Thompson WG, Irvine EJ, Rance L. An epidemiological survey of constipation in Canada: definitions, rates, demographics, and predictors of health care seeking. Am J Gastroenterol 2001; 96: 31307.
    Direct Link:
  • 2
    McCrea GL, Miaskowski C, Stotts NA, Macera L, Varma MG. A review of the literature on gender and age differences in the prevalence and characteristics of constipation in North America. J Pain Symptom Manage 2009; 37: 73745.
  • 3
    Surrenti E, Rath DM, Pemberton JH, et al. Audit of constipation in a tertiary referral gastroenterology practice. Am J Gastroenterol 1995; 90: 14715.
  • 4
    Rao SSC, Tuteja AK, Vellema T, Kempf J, Stessman M. Dyssynergic defecation: demographics, symptoms, stool patterns, and quality of life. J Clin Gastroenterol 2004; 38: 6805.
  • 5
    Johanson JF, Kralstein J. Chronic constipation: a survey of the patient perspective. Aliment Pharmacol Ther 2007; 25: 599608.
  • 6
    Bleijenberg G, Kuijpers HC. Treatment of the spastic pelvic floor syndrome with biofeedback. Dis Colon Rectum 1987; 30: 10811.
  • 7
    Chiarioni G, Heymen S, Whitehead WE. Biofeedback therapy for dyssynergic defecation. World J Gastroenterol 2006; 12: 706974.
  • 8
    Heymen S, Scarlett Y, Jones K, Ringel Y, Drossman D, Whitehead WE. Randomized, controlled trial shows biofeedback to be superior to alternative treatments for patients with pelvic floor dyssynergia-type constipation. Dis Colon Rectum 2007; 50: 42841.
  • 9
    Chiarioni G, Whitehead WE, Pezza V, Morelli A, Basotti G. Biofeedback is superior to laxatives for normal transit constipation due to pelvic floor dyssynergia. Gastroenterology 2006; 130: 65764.
  • 10
    Rao SSC, Seaton K, Miller M, et al. Randomized controlled trial of biofeedback, sham feedback, and standard therapy for dyssynergic defecation. Clin Gastroenterol and Hepatol 2007; 5: 3318.
  • 11
    Gilliland R, Heymen S, Altomare F, Park UC, Vickers D, Wexner SD. Outcome and predictors of success of biofeedback for constipation. Br J Surg 1997; 84: 11236.
  • 12
    Chiarioni G, Salandini L, Whitehead WE. Biofeedback benefits only patients with outlet dysfunction, not patients with isolated slow transit constipation. Gastroenterology 2005; 129: 8697.
  • 13
    Song HJ, Jung SA, Noh YW, et al. Predictable factors of biofeedback therapy compliance in patients with chronic constipation due to pelvic floor dyssynergia. Am J Gastroenterol 2009; 104: A1319.
  • 14
    Fernandez-Fraga X, Azpiroz F, Casaus M, Aparici A, Malagelada J-R. Responses of anal constipation to biofeedback treatment. Scan J Gastroenterol 2005; 40: 207.
  • 15
    Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 46470.
  • 16
    Bassotti G, Chistolini F, Sietchiping-Nzepa F, de Roberto G, Morelli A, Chiarioni G. Biofeedback for pelvic floor dysfunction in constipation. BMJ 2004; 328: 3936.
  • 17
    Heymen S, Jones KR, Scarlett Y, Whitehead WE. Biofeedback treatment of constipation: a critical review. Dis Colon Rectum 2003; 46: 120817.
  • 18
    Rao SS, Welcher KD, Pelsang RE. Effects of biofeedback therapy on anorectal function in obstructive defecation. Dig Dis Sci 1997; 42: 2197205.
  • 19
    Shim L, Prott G, Hansen RD, Simmons LE, Kellow JE, Malcolm A. Prolonged balloon expulsion is predictive of abdominal distension in bloating. Am J Gastroenterol 2010; 105: 8837.
  • 20
    Thompson WG. Appendix B: research diagnostic questions for functional gastrointestinal disorders: Rome II Integrative Questionnaire. In: DrossmanDA, ed. The Functional Gastrointestinal Disorders: Diagnosis, Pathophysiology, and Treatment: A Multinational Consensus, 2nd ed. McLean, VA: Degnon Associates, 2000; 35191.
  • 21
    Knowles CH, Eccersley AJ, Scott SM, et al. Linear discriminant analysis of the symptoms in patients with chronic constipation: validation of new scoring system (KESS). Dis Colon Rectum 2000; 43: 141926.
  • 22
    Zigmond A, Snaith R. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 36170.
  • 23
    Wald A, Bharucha A, Enck P, et al. Functional anorectal disorders. In: DrossmanDA, ed. Rome III: The Functional Gastrointestinal Disorders, 3rd ed. Virginia, USA: McLean, Degnon Associates, 2006; 66375.
  • 24
    Suttor VP, Prott GM, Hansen RD, Kellow JE, Malcolm A. Evidence for pelvic floor dyssynergia in patients with irritable bowel syndrome. Dis Colon Rectum 2010; 53: 15660.
  • 25
    Sun WM, Read NW, Prior A, et al. Sensory and motor responses to rectal distension vary according to rate and pattern of balloon inflation. Gastroenterology 1990; 99: 100815.
  • 26
    Dobson A, Barnett A. An Introduction to Generalized Linear Models, 3rd ed. Boca Raton: CRC Press, 2008; 126.
  • 27
    Harrell FE Jr, Lee KL, Mark DB. Multivariate prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15: 36187.
  • 28
    Steyerberg ES, Eijkemans MJC, Harrell F, Habbema JDF. Prognostic modeling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. Stat Med 2000; 19: 105979.
  • 29
    Bajwa A, Emmanuel A. The physiology of continence and evacuation. Best Pract Res Clin Gastroenterol 2009; 23: 47785.
  • 30
    Rao SSC, Mudipalli RS, Stessman M, et al. Investigation of the utility of colorectal function tests and Rome II criteria in dyssynergic defecation (Anismus). Neurogastroenterol Motil 2004; 16: 58996.